What are clinicians now required to specify regarding substance use disorders in DSM-5?

• A. Severity ratings of mild, moderate, and severe
• B. Types of treatment required
• C. Duration of addiction
• D. Specific substances involved

Answer: (A)

In the DSM-5, clinicians are indeed required to specify the severity of substance use disorders as mild, moderate, or severe. This categorization is important because it helps to create a more individualized treatment plan and facilitates more precise communication among healthcare providers regarding the patient's condition.

The severity ratings are based on the number of diagnostic criteria met by the individual, which can guide treatment decisions and the intensity of intervention needed. Mild disorders may require less intensive treatment, while severe disorders might indicate the need for comprehensive, possibly long-term care.

While treatment types, duration of addiction, and specific substances are significant aspects of understanding and addressing substance use disorders, the DSM-5 specifically emphasizes the severity of the disorder as a key component in its diagnostic criteria. This focus on severity reflects an evolving understanding of substance use disorders and the importance of tailoring interventions according to the severity of an individual's situation.